Document is current
Any future updates will be listed below
-
Authors
Sustek, Samantha
Messick, Troy E.
Dheekollu, Jayaraju
Albitz, Coltin
Chen, Christopher
Faustino, Anneliese
Tang, Hsin-Yao
Kim, Hee Jong
Murakami, Kenji
Lieberman, Paul M.
-
Funding
Funding for this research was provided by:
NCI (75N91019D00024)
NCI (75N91019D00024)
NCI (75N91019D00024)
NIH NCI (R01 CA259171)
NIH NCI (R01 CA140652)
NIH GM (R01GM123233)
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 28 February 2026
First Online: 9 April 2026
Declarations
:
: PML is a founder of Vironika LLC and is listed on patents relating to EBNA1 inhibitors. PML has served on advisory panels for Pfizer, GSK, Sanofi, Merck, and Moderna.
